Skip to Content
  1. All Products
  2. Disorders of Complement System
  3. RET (NSCLC) (SDL12292)
-
RET (NSCLC) (SDL12292)

RET (NSCLC) (SDL12292)

https://www.scanlabglobal.com/web/image/product.template/7551/image_1920?unique=18393fc
Tests RET fusions in NSCLC tissue for therapy planning. Positive results guide selpercatinib or pralsetinib for lung cancer.

1,480.00 AED 1480.0 AED 1,480.00 AED

1,480.00 AED

Not Available For Sale

This combination does not exist.

Contact Us

Terms and Conditions

Share